DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,673,240 | -69.9% | 2,403,915 | -19.7% | 0.00% | -100.0% |
| Q2 2023 | $18,862,523 | +2.6% | 2,994,051 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $18,382,592 | -48.9% | 3,185,891 | -9.2% | 0.00% | 0.0% |
| Q4 2022 | $35,992,328 | -40.2% | 3,508,024 | -2.5% | 0.00% | -50.0% |
| Q3 2022 | $60,177,000 | +21.4% | 3,599,125 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $49,559,000 | -2.6% | 3,539,936 | +12.3% | 0.00% | +100.0% |
| Q1 2022 | $50,887,000 | +7.3% | 3,150,820 | +42.2% | 0.00% | 0.0% |
| Q4 2021 | $47,438,000 | +146.0% | 2,215,624 | +68.8% | 0.00% | 0.0% |
| Q3 2021 | $19,282,000 | -30.9% | 1,312,664 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $27,911,000 | +18.0% | 1,403,342 | +77.4% | 0.00% | 0.0% |
| Q1 2021 | $23,652,000 | – | 791,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,626,476 | $78,771,000 | 38.55% |
| Logos Global Management LP | 2,797,501 | $39,165,000 | 7.18% |
| Cormorant Asset Management, LP | 5,500,000 | $77,000,000 | 5.82% |
| Ghost Tree Capital, LLC | 275,000 | $3,850,000 | 2.00% |
| EcoR1 Capital, LLC | 2,634,178 | $36,878,000 | 1.27% |
| RA Capital Management | 2,186,636 | $30,613,000 | 0.82% |
| Vivo Capital, LLC | 476,589 | $6,672,000 | 0.67% |
| Avoro Capital Advisors LLC | 2,222,222 | $31,111,000 | 0.62% |
| Artal Group S.A. | 400,000 | $5,600,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $6,445,000 | 0.19% |